Monday 01 June 2026
Internal Reference Number: FOI_9409
Date Request Received: 18/05/2026 00:00:00
Date Request Replied To: 26/05/2026 00:00:00
This response was sent via: By Email
Request Summary: Intra-vitreal injections or implants
Request Category: Researcher
| Question Number 1: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2026: • Aflibercept - Eylea • Aflibercept - Biosimilar • Bevacizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - including all Biosimilars | |
| Answer To Question 1: Please find our response to all questions in the spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  13745 - FOI_9409 - Intra-vitreal injections or implants - FOR ISSUE.xlsx | |
| Question Number 2: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2026: • Aflibercept - Eylea • Aflibercept - Biosimilar • Bevacizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - including all Biosimilars Please see attached | |
| Answer To Question 2: Please find our response to all questions in the spreadsheet attached. To accompany this answer to question 2 please also see the documents listed below:  FOI 9409 - Q2.docx | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
